+35.4%
CVS vs CHTR
-41.9%
+77.4%
-16.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CHTR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.5% | +0.4% | -0.9% | -0.5% |
| 7D | +4.0% | -1.1% | +5.0% | +4.0% |
| 30D | -2.4% | -0.8% | -1.6% | -2.4% |
| 3M | +2.7% | +17.8% | -15.1% | +1.7% |
| 6M | +21.9% | -34.5% | +56.4% | +26.4% |
| YTD | +24.7% | -27.2% | +51.9% | +24.3% |
| 1Y | +35.4% | -41.4% | +76.9% | +38.5% |
| All | +35.4% | -41.9% | +77.4% | +38.5% |
Cumulative growth
Daily Returns
Daily percentage return beside CHTR.
Daily Out/Under-Performance
Portfolio return minus CHTR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CHTR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CHTR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling